70 related articles for article (PubMed ID: 20408130)
1. HnRNP K and PDI marked response to chemotherapy to human colorectal cancer cells.
Zhang P; Huang L; Ma YL; Peng JY; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
Electrophoresis; 2010 May; 31(10):1731-8. PubMed ID: 20408130
[TBL] [Abstract][Full Text] [Related]
2. [Proteomic research of biomarker of colorectal cancer metastasis].
Zhang P; Huang L; Ma YL; Peng JY; Shen TY; Chen HQ; Zhou YK; Chu ZX; Zhang M; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):618-22. PubMed ID: 19921578
[TBL] [Abstract][Full Text] [Related]
3. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.
Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT
Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723
[TBL] [Abstract][Full Text] [Related]
4. [Screening and identifying differentially expressed proteins in LST-R1 cells].
Tong HS; Lai XR; Zhang YL; Jiang B; Su L
Ai Zheng; 2008 Dec; 27(12):1277-82. PubMed ID: 19079993
[TBL] [Abstract][Full Text] [Related]
5. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
Qu LJ; Ding YQ; Liang L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
[TBL] [Abstract][Full Text] [Related]
7. [Enhanced anticancer effects of 5'-DFUR on colorectal cancer cell lines SW480 and LOVO by transfection with thymidine phosphorylase cDNA].
Liu J; Zhang JM; Gao Q; Wang QW; Ye DJ; Liu Y
Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):636-40. PubMed ID: 24256592
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis.
Tanaka S; Sakai A; Kimura K; Yoshida H; Fushitani H; Ogata A; Miyamoto A; Fukushima M; Wada A; Tanigawa N
Int J Oncol; 2008 Aug; 33(2):361-70. PubMed ID: 18636157
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer.
Carpenter B; McKay M; Dundas SR; Lawrie LC; Telfer C; Murray GI
Br J Cancer; 2006 Oct; 95(7):921-7. PubMed ID: 16953238
[TBL] [Abstract][Full Text] [Related]
10. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
11. Characterization of multiple alternative forms of heterogeneous nuclear ribonucleoprotein K by phosphate-affinity electrophoresis.
Kimura Y; Nagata K; Suzuki N; Yokoyama R; Yamanaka Y; Kitamura H; Hirano H; Ohara O
Proteomics; 2010 Nov; 10(21):3884-95. PubMed ID: 20960454
[TBL] [Abstract][Full Text] [Related]
12. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer.
Liu L; Zhao L; Zhang Y; Zhang Q; Ding Y
Cell Biol Int; 2007 Aug; 31(8):805-14. PubMed ID: 17376711
[TBL] [Abstract][Full Text] [Related]
14. Differential protein expression and novel biomarkers related to 5-FU resistance in a 3D colorectal adenocarcinoma model.
Lee SH; Nam JK; Park JK; Lee JH; Min do S; Kuh HJ
Oncol Rep; 2014 Oct; 32(4):1427-34. PubMed ID: 25050539
[TBL] [Abstract][Full Text] [Related]
15. [Screening human gastric carcinoma-associated antigens by serologic proteome analysis].
Zeng X; Liao AJ; Tang HL; Yi L; Xie N; Su Q
Ai Zheng; 2007 Oct; 26(10):1080-4. PubMed ID: 17927877
[TBL] [Abstract][Full Text] [Related]
16. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
[TBL] [Abstract][Full Text] [Related]
17. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors.
Xiao Z; Ko HL; Goh EH; Wang B; Ren EC
Carcinogenesis; 2013 Jul; 34(7):1458-67. PubMed ID: 23455382
[TBL] [Abstract][Full Text] [Related]
18. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
[TBL] [Abstract][Full Text] [Related]
19. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
[TBL] [Abstract][Full Text] [Related]
20. Compartmentalization of hnRNP-K during cell cycle progression and its interaction with calponin in the cytoplasm.
Laury-Kleintop LD; Tresini M; Hammond O
J Cell Biochem; 2005 Aug; 95(5):1042-56. PubMed ID: 15962305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
